TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30605458

Group type: EXPERIMENTAL
Intervention: Positive suggestion regarding side effects
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control information about side effects
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combination of diclofenac and atropine
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: General Assessment of Side Effects (GASE) questionnaire
Number of subjects: 66
Study: 29792472

Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Vigorous exercise
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Baseline weekly cannabis use
Number of subjects: 46
Study: 26507722

Group type: EXPERIMENTAL
Intervention: Azilsartan medoxomil (AZL-M) 60 mg (3 × 20 mg capsules)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 24170388

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 9946

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 9946

Group type: EXPERIMENTAL
Intervention: Hs-TnT
Number of subjects: 9946

Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 9946

Group type: EXPERIMENTAL
Intervention: GDF-15
Number of subjects: 9946
Study: 22874004

Group type: EXPERIMENTAL
Intervention: Daily text messages via mobile phone for 6 weeks
Number of subjects: 205
Study: 19739972

Group type: EXPERIMENTAL
Intervention: Antimicrobial-resistant infection (ARI) patients
Number of subjects: 1391
Study: 17149758

Group type: EXPERIMENTAL
Intervention: Enhanced counseling (EC)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 297
Study: 14976169

Group type: EXPERIMENTAL
Intervention: Community intervention 'Hartslag Limburg'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 11466159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23201

Group type: EXPERIMENTAL
Intervention: Investigational antidepressants (venlafaxine ER and citalopram)
Number of subjects: 23201

Group type: EXPERIMENTAL
Intervention: Active comparators
Number of subjects: 23201

Group type: EXPERIMENTAL
Intervention: Investigational antidepressants
Number of subjects: 23201
Study: 9554338

Group type: EXPERIMENTAL
Intervention: Intravesical bacillus Calmette-Guerin (BCG)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8113822

Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic men
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic men who accepted the disease label (n = 73)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Deniers (n = 122)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic men who deny having hypercholesterolemia
Number of subjects: 523
Study: 3289645

Group type: EXPERIMENTAL
Intervention: Relaxation technique
Number of subjects: 16

Group type: COMPARATOR
Intervention: Reading program (Control)
Number of subjects: 16
Study: 29334530

Group type: EXPERIMENTAL
Intervention: Portal and antegrade arterial flush
Number of subjects: 80

Group type: COMPARATOR
Intervention: Portal flush only
Number of subjects: 80
Study: 28675578

Group type: EXPERIMENTAL
Intervention: Financial intervention (bonus of 20 RMB for each ADR report and a fine of 50 RMB for withheld reports)
Number of subjects: 0
Study: 26325387

Group type: EXPERIMENTAL
Intervention: ALB treatment
Number of subjects: 830

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 830
Study: 24034304

Group type: EXPERIMENTAL
Intervention: FOS (5 g/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (sucrose)
Number of subjects: 43
Study: 21347970

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training at 50% maximal inspiratory mouth pressure (PImax)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle warm-up at 40% PImax
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combined inspiratory muscle training and warm-up
Number of subjects: 12

Group type: COMPARATOR
Intervention: Inspiratory muscle training at 15% PImax (control group)
Number of subjects: 12
Study: 19358790

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 150 mg/day
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg/day
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/day
Number of subjects: 612

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 612
Study: 17575751

Group type: EXPERIMENTAL
Intervention: Laparoscopic interventions in transplant recipients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laparoscopic interventions
Number of subjects: 0
Study: 12752867

Group type: EXPERIMENTAL
Intervention: Experimental group changed body position hourly (supine, right side-lying, left side-lying) for the first 7 hours after coronary angiography.
Number of subjects: 419

Group type: COMPARATOR
Intervention: Control group received usual care, remaining supine and flat for 8-24 hours with the affected leg straight.
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Both groups experienced increased back pain intensity with longer time on bedrest.
Number of subjects: 419

Group type: COMPARATOR
Intervention: Experimental group vs Control group regarding vascular complications (bleeding at femoral site).
Number of subjects: 419
Study: 11251497

Group type: EXPERIMENTAL
Intervention: Continuity of midwifery care (team care)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1000
Study: 9065356

Group type: EXPERIMENTAL
Intervention: Early follow-up service provided by OXHIS at 7-10 days post-injury
Number of subjects: 579

Group type: COMPARATOR
Intervention: Postal information alone
Number of subjects: 579

Group type: COMPARATOR
Intervention: Telephone contact, advice and information
Number of subjects: 579

Group type: COMPARATOR
Intervention: In-person assessment and advice
Number of subjects: 579

Group type: COMPARATOR
Intervention: Telephone support
Number of subjects: 579

Group type: COMPARATOR
Intervention: Further face-to-face contact
Number of subjects: 579
Study: 8417384

Group type: EXPERIMENTAL
Intervention: Deprenyl (10 mg per day)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Tocopherol (2000 IU per day)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Active deprenyl and tocopherol placebo
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Active tocopherol and deprenyl placebo
Number of subjects: 800
Study: 3530158

Group type: EXPERIMENTAL
Intervention: Chloroquine 600 mg base once, followed by proguanil 100 mg per day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Iron 60 mg daily
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Folic acid 1 mg daily
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Iron plus folic acid
Number of subjects: 200

Group type: COMPARATOR
Intervention: No active treatment (Control group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Proguanil (as part of the antimalarial regimen)
Number of subjects: 200
Study: 30428521

Group type: EXPERIMENTAL
Intervention: Cycling at 45 min after baseline
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cycling at 15 min after baseline
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 78
Study: 26615182

Group type: EXPERIMENTAL
Intervention: Clinical decision support for renal dosage adjustments
Number of subjects: 1278

Group type: COMPARATOR
Intervention: Usual workflow (Control)
Number of subjects: 1278

Group type: EXPERIMENTAL
Intervention: Prospective alerts
Number of subjects: 1278

Group type: EXPERIMENTAL
Intervention: Look-back alerts
Number of subjects: 1278
Study: 24618630

Group type: EXPERIMENTAL
Intervention: Nasopore® packing
Number of subjects: 47

Group type: COMPARATOR
Intervention: No nasal packing (Control)
Number of subjects: 47
Study: 22539568

Group type: EXPERIMENTAL
Intervention: bilateral continuous theta burst stimulation (cTBS) at the temporal cortex
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: bilateral continuous theta burst stimulation (cTBS) at the temporoparietal cortex
Number of subjects: 48

Group type: COMPARATOR
Intervention: sham condition behind the mastoid
Number of subjects: 48
Study: 20304677

Group type: EXPERIMENTAL
Intervention: Kyphoplasty
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no kyphoplasty)
Number of subjects: 40
Study: 17382150

Group type: EXPERIMENTAL
Intervention: Invasively estimated International Continence Society obstruction classification
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Noninvasively assessed bladder outlet obstruction probability
Number of subjects: 150

Group type: COMPARATOR
Intervention: Treatment recommendations based on BOO classification
Number of subjects: 150

Group type: COMPARATOR
Intervention: Treatment recommendations based on BOO probability
Number of subjects: 150
Study: 16333173

Group type: COMPARATOR
Intervention: Single plane incision (1.5 mm)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Two plane incision (2 mm)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Three plane incision (2.5 mm)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Viscoelastic injection
Number of subjects: 240

Group type: COMPARATOR
Intervention: No viscoelastic injection
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Incision length 2 mm
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Incision length 2.5 mm
Number of subjects: 240
Study: 12477503

Group type: EXPERIMENTAL
Intervention: Long‐protocol pituitary down‐regulation followed by FSH stimulation; vaginal progesterone for luteal support
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no OHSS)
Number of subjects: 18
Study: 9445205

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg 3 times a day orally, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (n=20)
Number of subjects: 40
Study: 7612367

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 0
Study: 2196494

Group type: EXPERIMENTAL
Intervention: Vaginal ultrasonography with a 240 degrees scanning angle
Number of subjects: 201

Group type: COMPARATOR
Intervention: Digital examination
Number of subjects: 201
Study: 92877

Group type: EXPERIMENTAL
Intervention: Aprotinin (Trasylol) administered intravenously
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 31422392

Group type: EXPERIMENTAL
Intervention: Desmopressin combined with 5 mg imipramine at bedtime
Number of subjects: 40

Group type: COMPARATOR
Intervention: Desmopressin alone
Number of subjects: 40
Study: 28755307

Group type: EXPERIMENTAL
Intervention: Repetition of Epley maneuver
Number of subjects: 144

Group type: COMPARATOR
Intervention: Switch to Semont maneuver
Number of subjects: 144
Study: 25761943

Group type: EXPERIMENTAL
Intervention: Proximal gastric bypass (150 cm alimentary limb)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Distal gastric bypass (150 cm common channel)
Number of subjects: 115
Study: 24167552

Group type: EXPERIMENTAL
Intervention: Altitude 1630 m
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Altitude 2590 m
Number of subjects: 44

Group type: COMPARATOR
Intervention: Baseline (490 m)
Number of subjects: 44
Study: 21233404

Group type: EXPERIMENTAL
Intervention: Tipifarnib and bortezomib combination
Number of subjects: 0
Study: 19470174

Group type: EXPERIMENTAL
Intervention: Low-dose risperidone
Number of subjects: 56

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 56
Study: 17185150

Group type: EXPERIMENTAL
Intervention: Soft silicone tunneled catheters (ST)Caths
Number of subjects: 30

Group type: COMPARATOR
Intervention: Twin polyurethane nontunneled femoral catheters
Number of subjects: 30
Study: 16327534

Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation program
Number of subjects: 60
Study: 11878034

Group type: EXPERIMENTAL
Intervention: Education outreach visits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reminders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multifaceted strategies tailored to the particular setting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 10325282

Group type: EXPERIMENTAL
Intervention: CSF‐1 concentrations in follicular fluid during ovulatory phase
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: CSF‐1 concentrations in follicular fluid at oocyte retrieval
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: CSF‐1 concentrations in plasma on day 9 after HCG
Number of subjects: 27

Group type: COMPARATOR
Intervention: CSF‐1 concentrations in plasma during ovarian stimulation
Number of subjects: 27

Group type: COMPARATOR
Intervention: CSF‐1 concentrations in blood during the menstrual cycle
Number of subjects: 27
Study: 8756739

Group type: EXPERIMENTAL
Intervention: Prostatic carcinoma patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Benign prostatic hyperplasia patients (control)
Number of subjects: 20
Study: 1840337

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 7288001

Group type: EXPERIMENTAL
Intervention: Internal attribution manipulations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General attribution conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: External attribution conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Specific attribution conditions
Number of subjects: 0
Study: 31133061

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (0.3 mg/kg in 0.9% sodium chloride, 100 ml bag) in addition to standard intravenous hydration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dose of morphine (0.1 mg/kg in 0.9% sodium chloride, 100 ml bag) in addition to standard intravenous hydration
Number of subjects: 0
Study: 28195835

Group type: EXPERIMENTAL
Intervention: Simulation-based Neonatal Resuscitation Program (NRP) curriculum
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Rolling refresher training at varied time intervals
Number of subjects: 25
Study: 26341706

Group type: EXPERIMENTAL
Intervention: 5-virus laboratory-generated PCR bundle
Number of subjects: 0

Group type: COMPARATOR
Intervention: 17-virus FilmArray PCR platform
Number of subjects: 0
Study: 23800106

Group type: EXPERIMENTAL
Intervention: Very Early Supported Discharge (VESD)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ordinary discharge
Number of subjects: 44
Study: 21067716

Group type: EXPERIMENTAL
Intervention: Endometrial biopsy assessed for the presence of nucleolar channel systems (NCSs) by indirect immunofluorescence.
Number of subjects: 175
Study: 19225434

Group type: EXPERIMENTAL
Intervention: ACUVUE 2
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: ACUVUE ADVANCE
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: O2OPTIX
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: NIGHT & DAY
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: PureVision
Number of subjects: 28
Study: 17088002

Group type: EXPERIMENTAL
Intervention: Garlic
Number of subjects: 4102

Group type: EXPERIMENTAL
Intervention: Garlic tablets
Number of subjects: 4102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4102
Study: 15178687

Group type: EXPERIMENTAL
Intervention: Isohumulones (isohumulone and isocohumulone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isohumulones
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pioglitazone
Number of subjects: 0
Study: 12529070

Group type: EXPERIMENTAL
Intervention: Alcohol beverage
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 204
Study: 9693288

Group type: EXPERIMENTAL
Intervention: Plate haptic silicone lens (Silens PH)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Three-piece silicone intraocular lens (CeeOn)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (Plate haptic and Three-piece)
Number of subjects: 100
Study: 8595925

Group type: EXPERIMENTAL
Intervention: Patients with SLE
Number of subjects: 37

Group type: COMPARATOR
Intervention: Healthy normal subjects
Number of subjects: 37
Study: 2653041

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids
Number of subjects: 27

Group type: COMPARATOR
Intervention: Tocolysis, prophylactic antibiotics, and other interventions
Number of subjects: 27
Study: 365249

Group type: EXPERIMENTAL
Intervention: Portable constant‐cuff blood pressure feedback technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Meditation-relaxation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 30
Study: 31859246

Group type: EXPERIMENTAL
Intervention: CDKI plus aromatase inhibitor
Number of subjects: 4200

Group type: EXPERIMENTAL
Intervention: CDKI plus fulvestrant
Number of subjects: 4200

Group type: EXPERIMENTAL
Intervention: CDKI plus fulvestrant (second-line and beyond)
Number of subjects: 4200

Group type: COMPARATOR
Intervention: Placebo plus aromatase inhibitor
Number of subjects: 4200

Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 4200
Study: 30728027

Group type: EXPERIMENTAL
Intervention: D2 plus radical surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: D2 radical surgery
Number of subjects: 70
Study: 28898485

Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz, 5 s-on, 10 s-off, 100% motor threshold, 3,000 pulses)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 11
Study: 25495101

Group type: EXPERIMENTAL
Intervention: Rehydration (RE: water equal to 175% of body mass loss (BML))
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hypohydration (HYPO: 200 ml water)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rehydration (RE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hypohydration (HYPO)
Number of subjects: 10
Study: 23352582

Group type: EXPERIMENTAL
Intervention: TVT-O
Number of subjects: 154
Study: 21889073

Group type: EXPERIMENTAL
Intervention: Fluoridated miswaks impregnated in 0.5% sodium fluoride (test group, n=19)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Nonfluoridated miswaks (control group, n=18)
Number of subjects: 37
Study: 19001447

Group type: EXPERIMENTAL
Intervention: Structured therapy interruption (STI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Continuous HAART
Number of subjects: 120
Study: 16882745

Group type: EXPERIMENTAL
Intervention: Acyline (long‐acting GnRH‐antagonist) every 2 weeks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Acyline plus testosterone (T) gel (10 mg/d)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 15172401

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose)
Number of subjects: 23
Study: 11284483

Group type: EXPERIMENTAL
Intervention: Timolol maleate 0.50%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Betaxolol HCl 0.50%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carteolol 1%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Levobunolol 0.50%
Number of subjects: 40
Study: 9205920

Group type: EXPERIMENTAL
Intervention: Bioactive glass (Perioglas)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Surgical debridement only (Control)
Number of subjects: 20
Study: 8387176

Group type: EXPERIMENTAL
Intervention: Mitomycin, ifosfamide, and cisplatin (MIC)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Radiotherapy in combination with MIC
Number of subjects: 74

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 74
Study: 2450244

Group type: EXPERIMENTAL
Intervention: Nicardipine 30 mg t.i.d. (three times a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicardipine combined with enalapril
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo with enalapril
Number of subjects: 12
Study: 29381241

Group type: EXPERIMENTAL
Intervention: incisional negative pressure wound therapy (iNPWT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: standard dressing
Number of subjects: 33
Study: 27377115

Group type: EXPERIMENTAL
Intervention: Topical anaesthetic agent plus low-power laser
Number of subjects: 66

Group type: COMPARATOR
Intervention: Topical anaesthetic agent (benzocaine)
Number of subjects: 66
Study: 25382325

Group type: EXPERIMENTAL
Intervention: Mizoribine (MZR) 300 mg every other day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 g per day in two divided doses
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide (CYC) 0.5 g every 2 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mizoribine (MZR)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide (CYC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) or Intravenous cyclophosphamide (CYC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Mizoribine (MZR) or Mycophenolate mofetil (MMF)
Number of subjects: 90

Group type: COMPARATOR
Intervention: CYC
Number of subjects: 90
Study: 23548682

Group type: EXPERIMENTAL
Intervention: Reminiscing training (four weekly in-home sessions in elaborative and emotion-rich reminiscing)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (wait-list condition)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Reminiscing training
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study: 20610096

Group type: EXPERIMENTAL
Intervention: Crystalens AT‐45 IOL accommodating IOL
Number of subjects: 25
Study: 19033608

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Fluid restriction (FR)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Energy restriction (ER)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Fluid and energy restriction (F+ER)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Dietary restriction (ER and F+ER)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Refeeding after exercise
Number of subjects: 13
Study: 16809897

Group type: EXPERIMENTAL
Intervention: 100 mg of iron sucrose
Number of subjects: 12
Study: 14722005

Group type: EXPERIMENTAL
Intervention: Automated Symmetry anastomoses
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventionally hand-sewn anastomoses
Number of subjects: 50
Study: 12052450

Group type: EXPERIMENTAL
Intervention: Progressive, resistive back‐strengthening exercises
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 50